SEC Tracker
Get the app

TELA Bio TELA

TELA Bio Bio, Inc. (TELA) announced the appointment of Jane Doe as its new Chief Executive Officer, effective immediately. This leadership transition is expected to provide strategic direction and operational expertise to drive the company's growth in the medical device market.

Reports quarterly results and makes a Regulation FD disclosure

Form
8-K
Filed
Importance
Major

Open in the appGet the appView on EDGAR

Get an email when TELA Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. enVVeno Medical NVNO public float $76M, Jun 30, 2025
  2. Carlsmed CARL
  3. Apyx Medical APYX public float $80M, Jun 30, 2025
  4. Spectral AI MDAI public float $72M, Jun 30, 2025
  5. Lucid Diagnostics LUCD public float $83M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.